HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Connexin expression by human granulosa cell tumors: Identification of connexin 32 as a tumor signature.

Abstract
Human granulosa cell (GC)-tumors are assumed to arise from ovarian GCs but to what extent they resemble normal human GCs is not well established. We examined whether a prominent feature of normal GCs, expression of the major gap junctional protein connexin 43 (Cx43), was retained in 14 human GC-tumor samples. Immunohistochemistry revealed areas of strong staining side by side with areas of weak and/or no staining. If present, cytoplasmic and membrane-associated Cx43 staining occurred. In cells with reduced or absent Cx43, another Cx was found, Cx32. Cx32, which is absent from non-tumor GCs, was present in GC-tumor cells co-expressed in part with Cx43 at gap junctional plaques. Expression of Cx32 and Cx43 was confirmed by RT-PCR and sequencing in the majority of tumor samples. Thus GC-tumor cells are characterized by a partial or complete loss of Cx43 expression and expression of Cx32, which may be a marker for these rare tumors. It is possible that the pattern of Cxs may contribute to tumor formation and growth, as it may indicate aberrant and/or reduced cell-to-cell communication ability.
AuthorsCatherina Lücke, Silvana Siebert, Doris Mayr, Artur Mayerhofer
JournalCancer biomarkers : section A of Disease markers (Cancer Biomark) 2010-2011 Vol. 8 Issue 3 Pg. 137-44 ISSN: 1875-8592 [Electronic] Netherlands
PMID22012769 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Connexin 43
  • Connexins
  • RNA, Messenger
  • connexin 32
Topics
  • Adult
  • Aged
  • Biomarkers, Tumor (biosynthesis)
  • Cell Communication
  • Child
  • Connexin 43 (biosynthesis, metabolism)
  • Connexins (biosynthesis, metabolism)
  • Female
  • Gap Junctions (metabolism)
  • Granulosa Cell Tumor (metabolism)
  • Humans
  • Middle Aged
  • Ovarian Neoplasms (metabolism)
  • RNA, Messenger (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: